-
公开(公告)号:US20050235436A1
公开(公告)日:2005-10-27
申请号:US11148043
申请日:2005-06-08
Applicant: Kirkland Vogt , Kimberly Gillis , Daniel McBride , John Soltis , William Sims
Inventor: Kirkland Vogt , Kimberly Gillis , Daniel McBride , John Soltis , William Sims
IPC: D06M11/155 , D06M11/17 , D06M11/20 , D06M13/282 , D06M13/325 , D06M13/46 , D06M15/423 , D06N7/04 , D06P1/52 , D06P1/645 , D06P1/673 , D06P5/30 , D06P3/82
CPC classification number: D06M13/46 , D06M11/155 , D06M11/17 , D06M11/20 , D06M13/282 , D06M13/325 , D06M15/423 , D06P1/5242 , D06P1/5257 , D06P1/645 , D06P1/655 , D06P1/673 , D06P5/30 , Y10T428/2395 , Y10T428/23986 , Y10T442/20 , Y10T442/2041 , Y10T442/2164 , Y10T442/218 , Y10T442/2189 , Y10T442/2197 , Y10T442/2205 , Y10T442/2221 , Y10T442/2238 , Y10T442/2246 , Y10T442/2254 , Y10T442/30 , Y10T442/40 , Y10T442/60
Abstract: A textile coated with a coating having cationic and repellant properties, thereby accepting an image thereon more readily.
Abstract translation: 涂覆有具有阳离子和驱虫性质的涂层的织物,从而更容易地接受其上的图像。
-
2.MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES 有权
Title translation: 用于预防和/或逆转新型自动免疫糖尿病的基于微阵列的组合物公开(公告)号:US20080039369A1
公开(公告)日:2008-02-14
申请号:US11834550
申请日:2007-08-06
Applicant: Larry Brown , Nick Giannoukakis , Kimberly Gillis
Inventor: Larry Brown , Nick Giannoukakis , Kimberly Gillis
IPC: A61K31/7088 , A61K38/28 , A61P3/10 , A61P37/00
CPC classification number: A61K31/7088 , A61K9/0024 , A61K9/1641 , A61K9/19 , A61K38/28 , C12N15/111 , C12N15/1138 , C12N2310/11 , C12N2310/315 , C12N2320/32 , A61K2300/00
Abstract: AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.
Abstract translation: AS寡核苷酸以微球形式递送,以诱导树突细胞耐受,特别是在非肥胖 - 糖尿病(NOD)小鼠模型中。 微球合并反义(AS)寡核苷酸。 一种方法包括使用反义方法在体内逆转NOD小鼠中的自身免疫性糖尿病状态。 靶向寡核苷酸以结合初级转录物CD40,CD80,CD86及其组合。
-
3.Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer 失效
Title translation: FKBP54在前列腺癌诊断和治疗中的表达分析公开(公告)号:US20050069946A1
公开(公告)日:2005-03-31
申请号:US10996096
申请日:2004-11-23
Applicant: Kimberly Gillis , Yixian Zhang
Inventor: Kimberly Gillis , Yixian Zhang
IPC: G01N33/50 , A61K31/7088 , A61K45/00 , A61K48/00 , A61P13/08 , A61P35/00 , C07K16/18 , C12N15/09 , C12Q1/02 , C12Q1/68 , G01N33/15 , G01N33/53 , G01N33/566 , G01N33/574 , G01N33/94
CPC classification number: C07K16/18 , C12Q1/6886 , C12Q2565/501 , C12Q2600/158 , G01N33/57434 , G01N33/9493 , G01N2500/00 , G01N2800/52
Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. FKBP markers are provided, wherein changes in the levels of expression of one or more of the FKBP markers is correlated with the presence of prostate cancer.
Abstract translation: 本发明涉及用于检测,表征,预防和治疗前列腺癌的组合物,试剂盒和方法。 提供FKBP标记,其中一种或多种FKBP标记的表达水平的变化与前列腺癌的存在相关。
-
-